The study’s conclusions are based on the findings that the rates of alanine aminotransferase elevations, aspartate aminotransferase elevations, anaemia, lymphopenia, and neutropenia in adults and children taking terbinafine or griseofulvin were low and equivalent to the baseline rates of abnormalities in this population.